Perrigo's OTC Priority Shows In Launch Of Imodium Multi-Symptom Equivalent
This article was originally published in The Pink Sheet & The Rose Sheet
Executive Summary
Perrigo is launching generic of J&J’s OTC Imodium Multi-Symptom Relief product for diarrhea and gas. An analyst estimates the product could generate $15m in annualized sales.